Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Mar 13, 2025

SELL
$19.27 - $24.63 $19,000 - $24,285
-986 Closed
0 $0
Q3 2022

Mar 13, 2025

BUY
$23.4 - $34.25 $23,072 - $33,770
986 New
986 $23.1 Million
Q4 2021

Mar 13, 2025

SELL
$28.67 - $37.13 $99,169 - $128,432
-3,459 Reduced 77.82%
986 $30 Million
Q2 2021

Mar 13, 2025

BUY
$28.45 - $38.0 $126,460 - $168,910
4,445 New
4,445 $135 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $2.34B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pko Investment Management Joint Stock CO Portfolio

Follow Pko Investment Management Joint Stock CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pko Investment Management Joint Stock CO, based on Form 13F filings with the SEC.

News

Stay updated on Pko Investment Management Joint Stock CO with notifications on news.